Table 2.
Immunohistochemistry profiles of aggressive uterine tumor resembling ovarian sex cord tumors cases.a
| Umeda, 2014 (1) | Umeda, 2014 (2) | Maczak, 2014 | Gomes, 2015 | Biermann, 2008 | O'Meara, 2009 | Endo, 2016 | Present case | |
|---|---|---|---|---|---|---|---|---|
| Calretinin | + | + | − | + | + | + | − | |
| EMA | − | − | − | + | ||||
| CK20 | − | |||||||
| CK19 | + | − | ||||||
| CK7 | − | − | − | |||||
| S100 | − | + | − | + | ||||
| Melan A | − | + | + | − | − | − | ||
| CK18 | + | |||||||
| AE1/AE3 | + | + | − | + | + | − | + | |
| Vimentin | + | + | + | + | + | + | ||
| Chromogranin | − | |||||||
| Synaptophysin | − | − | ||||||
| NSE | − | |||||||
| HMB45 | − | − | − | − | ||||
| PAX8 | + | |||||||
| WT1 | + | + | + | + | ||||
| FOXL2 | + | − | ||||||
| CD99 | + | + | − | + | + | + | − | + |
| CD56 | + | + | + | + | + | + | ||
| CD34 | − | − | − | |||||
| Inhibin | + | − | + | + | + | + | ||
| CD10 | − | + | − | + | + | |||
| aSMA | + | + | − | − | − | + | + | |
| Desmin | + | + | + | + | + | + | − | |
| h-Caldesmon | + | + | + | |||||
| Bcl2 | + | − | + | |||||
| HHF35 | + | + | − | − | ||||
| Calponin | + | |||||||
| ER | + | + | − | + | + | + | + | + |
| PR | + | + | − | + | + | + | + | − |
Abbreviations: aSMA, alpha-smooth muscle actin; bcl2, b-cell lymphoma #2; CK, cytokeratin; EMA, epithelial membrane antigen; ER, estrogen receptor; HMB, human melanoma black; NSE, neuron specific enolase; PR, progesterone receptor.
+ Present.
− Absent.
a
Blank fields denote unavailable data.